34 related articles for article (PubMed ID: 2115689)
1. Innovation in the discovery of the HIV-1 attachment inhibitor temsavir and its phosphonooxymethyl prodrug fostemsavir.
Wang T; Kadow JF; Meanwell NA
Med Chem Res; 2021; 30(11):1955-1980. PubMed ID: 34602806
[TBL] [Abstract][Full Text] [Related]
2. Assays to detect and characterize human immunodeficiency virus type 1 (HIV-1) receptor antagonists, compounds that inhibit binding of the HIV-1 surface glycoprotein, gp120, to the CD4 receptor on human T lymphocytes.
Clancy J; Tait-Kamradt A; Petitpas J; Manousos M; McGuirk PR; Subashi T; Watts P; Wondrack L
Antimicrob Agents Chemother; 1994 Sep; 38(9):2008-13. PubMed ID: 7811011
[TBL] [Abstract][Full Text] [Related]
3. Antiviral therapy for human immunodeficiency virus infections.
De Clercq E
Clin Microbiol Rev; 1995 Apr; 8(2):200-39. PubMed ID: 7542558
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of an HIV-binding recombinant fragment of human CD4.
Ryu SE; Kwong PD; Truneh A; Porter TG; Arthos J; Rosenberg M; Dai XP; Xuong NH; Axel R; Sweet RW
Nature; 1990 Nov; 348(6300):419-26. PubMed ID: 2247146
[TBL] [Abstract][Full Text] [Related]
5. Identification and structural analysis of residues in the V1 region of CD4 involved in interaction with human immunodeficiency virus envelope glycoprotein gp120 and class II major histocompatibility complex molecules.
Bowman MR; MacFerrin KD; Schreiber SL; Burakoff SJ
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):9052-6. PubMed ID: 1978941
[TBL] [Abstract][Full Text] [Related]
6. Cell receptors as drugs. Ligand binding domains of receptors as drugs: a potential new class of therapeutic agents.
Yarbrough GG; Taylor DP
J R Coll Physicians Lond; 1991 Oct; 25(4):309-11. PubMed ID: 1960687
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of a CD4 beta-turn mimetic that inhibits human immunodeficiency virus envelope glycoprotein gp120 binding and infection of human lymphocytes.
Chen S; Chrusciel RA; Nakanishi H; Raktabutr A; Johnson ME; Sato A; Weiner D; Hoxie J; Saragovi HU; Greene MI
Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5872-6. PubMed ID: 1352879
[TBL] [Abstract][Full Text] [Related]
8. Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis?
Herbeuval JP; Shearer GM
AIDS Rev; 2006; 8(1):3-8. PubMed ID: 16736946
[TBL] [Abstract][Full Text] [Related]
9. Prevention of HIV-1 infection and preservation of CD4 function by the binding of CPFs to gp120.
Finberg RW; Diamond DC; Mitchell DB; Rosenstein Y; Soman G; Norman TC; Schreiber SL; Burakoff SJ
Science; 1990 Jul; 249(4966):287-91. PubMed ID: 2115689
[TBL] [Abstract][Full Text] [Related]
10. CPF-DD is an inhibitor of infection by human immunodeficiency virus and other enveloped viruses in vitro.
Moore JP; Simpson G; McKeating JA; Burakoff SJ; Schreiber SL; Weiss RA
Virology; 1992 Jun; 188(2):537-44. PubMed ID: 1316672
[TBL] [Abstract][Full Text] [Related]
11. The interaction of CD4 with HIV-1 gp120.
Silberman SL; Goldman SJ; Mitchell DB; Tong AT; Rosenstein Y; Diamond DC; Finberg RW; Schreiber SL; Burakoff SJ
Semin Immunol; 1991 May; 3(3):187-92. PubMed ID: 1888898
[TBL] [Abstract][Full Text] [Related]
12. Molecular structures of CPF-dipeptides, inhibitors for the binding of CD4 with gp120.
Venkatramani L; Hossain MB; Van der Helm D
Int J Pept Protein Res; 1994 Jun; 43(6):520-8. PubMed ID: 7928082
[TBL] [Abstract][Full Text] [Related]
13. Priming of CD4+ T cells specific for conserved regions of human immunodeficiency virus glycoprotein gp120 in humans immunized with a recombinant envelope protein.
Abrignani S; Montagna D; Jeannet M; Wintsch J; Haigwood NL; Shuster JR; Steimer KS; Cruchaud A; Staehelin T
Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6136-40. PubMed ID: 1696717
[TBL] [Abstract][Full Text] [Related]
14. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.
Hart TK; Kirsh R; Ellens H; Sweet RW; Lambert DM; Petteway SR; Leary J; Bugelski PJ
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2189-93. PubMed ID: 2006155
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
